116 related articles for article (PubMed ID: 7741988)
1. The second generation CA 125 assays.
Kenemans P; Verstraeten AA; van Kamp GJ; von Mensdorff-Pouilly S
Ann Med; 1995 Feb; 27(1):107-13. PubMed ID: 7741988
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of the Elecsys CA 125 II assay.
Hubl W; Chan DW; Van Ingen HE; Miyachi H; Molina R; Filella X; Pitzel L; Ruibal A; Rymer JC; Bagnard G; Domke I
Anticancer Res; 1999; 19(4A):2727-33. PubMed ID: 10470230
[TBL] [Abstract][Full Text] [Related]
3. OVCA (CA125) second generation: technical aspects and serum levels in controls, patients with liver disease, pregnant women and patients with ovarian disease.
Cioffi M; Fratta M; Gazzerro P; Di Finizio B; Tucci A; Molinari AM
Tumori; 1997; 83(2):594-8. PubMed ID: 9226027
[TBL] [Abstract][Full Text] [Related]
4. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.
Kenemans P; van Kamp GJ; Oehr P; Verstraeten RA
Clin Chem; 1993 Dec; 39(12):2509-13. PubMed ID: 8252723
[TBL] [Abstract][Full Text] [Related]
5. Comparison of one first-generation and three second-generation methods for the determination of CA 125.
Martin MJ; Blockx PP
Int J Biol Markers; 1996; 11(1):36-9. PubMed ID: 8740640
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis.
Koper NP; Thomas CM; Massuger LF; Segers MF; Kiemeney LA; Verbeek AL
Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352
[TBL] [Abstract][Full Text] [Related]
7. Comparison of one first and three second generation methods for the determination of CA 125.
Martin M; Blockx P
Anticancer Res; 1997; 17(4B):3171-5. PubMed ID: 9329629
[TBL] [Abstract][Full Text] [Related]
8. No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays.
Barbati A; O'Brien TJ; Porpora MG; Orlacchio A; Cosmi EV
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):69-73. PubMed ID: 7493712
[TBL] [Abstract][Full Text] [Related]
9. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.
Kenemans P; Bon GG; Kessler AC; Verstraeten AA; van Kamp GJ
Clin Chem; 1992 Aug; 38(8 Pt 1):1466-71. PubMed ID: 1643716
[TBL] [Abstract][Full Text] [Related]
10. Discordant serum CA 125 values in commercial immunoassays.
van Kamp GJ; Verstraeten AA; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
[TBL] [Abstract][Full Text] [Related]
12. Technical evaluation of three second generation CA 125 assays.
Bonfrer JM; Baan AW; Jansen E; Lentfer D; Kenemans P
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):201-7. PubMed ID: 8031969
[TBL] [Abstract][Full Text] [Related]
13. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
Davelaar EM; Schutter EM; von Mensdorff-Pouilly S; van Kamp GJ; Verstraeten RA; Kenemans P
Ann Clin Biochem; 2003 Nov; 40(Pt 6):663-73. PubMed ID: 14629806
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of second generation CA 125 assays.
Cosmi EV; Atlante G; Donadio C; Mariani L; Barbati A
Eur J Obstet Gynecol Reprod Biol; 1995 Jan; 58(1):73-6. PubMed ID: 7758648
[TBL] [Abstract][Full Text] [Related]
15. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
Bon GG; von Mensdorff-Pouilly S; Kenemans P; van Kamp GJ; Verstraeten RA; Hilgers J; Meijer S; Vermorken JB
Clin Chem; 1997 Apr; 43(4):585-93. PubMed ID: 9105258
[TBL] [Abstract][Full Text] [Related]
16. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
Yedema KA; Thomas CM; Segers MF; Doesburg WH; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):245-52. PubMed ID: 1294413
[TBL] [Abstract][Full Text] [Related]
17. CA 19-9 and CA 125 determination by immunoluminometric assay.
Plebani M; Faggian D; Masiero M; Giacomini A; Burlina A
J Clin Chem Clin Biochem; 1990 Dec; 28(12):919-21. PubMed ID: 2081962
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Centcor CA 125 and CA 125 II assays.
Eltabbakh GH; Gupta MK; Belinson JL; Kennedy AW; Webster K; Paraiso MF
Eur J Gynaecol Oncol; 1996; 17(6):504-6. PubMed ID: 8971528
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
Bonfrer JM; Korse CM; Verstraeten RA; van Kamp GJ; Hart GA; Kenemans P
Clin Chem; 1997 Mar; 43(3):491-7. PubMed ID: 9068593
[TBL] [Abstract][Full Text] [Related]
20. Comparison of seven immunoassays for the quantification of CA 125 antigen in serum.
Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P
Clin Chem; 1998 Jul; 44(7):1417-22. PubMed ID: 9665418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
